AnalystsYun ZhongYun Zhong's Stock Forecasts
AnalystsYun Zhong
Sectors:
Industries:
Analyst Ranking
Bottom 7%
#4800 out of 5147 analysts
Average Return
-4.99%
Win Rate
42%19 out of 45
Risk vs Reward
Poor
Good
Yun Zhong's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Camp4 Therapeutics CorpCAMP | +202.01% | $1.99 | $6.01 | 2025-05-27 - 2025-12-11 | Buy |
Wave Life Sciences LtdWVE | +140.66% | $6.96 | $16.75 | 2025-06-23 - 2025-12-11 | Buy |
Wave Life Sciences LtdWVE | +130.72% | $7.26 | $16.75 | 2025-11-11 - 2025-12-11 | Buy |
Moonlake ImmunotherapeuticsMLTX | +96.23% | $7.17 | $14.07 | 2025-09-30 - 2025-12-11 | Buy |
Protagonist Therapeutics IncPTGX | +88.73% | $48.88 | $92.25 | 2025-03-28 - 2025-12-11 | Buy |
Yun Zhong Analyst Color
Get additional color on Yun Zhong's coverage of popular stocks
Yun Zhong's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sarepta Therapeutics IncSRPT | 5 | Buy | $32.00 | +47.13% | Initiates Coverage On | 4 days ago |
Ascendis Pharma AASND | 3 | Buy | $220.00 | +4.68% | Reiterates | 25 days ago |
Wave Life Sciences LtdWVE | 2 | Buy | $20.00 | +19.40% | Maintains | a month ago |
Keros Therapeutics IncKROS | 3 | Hold | $16.00 | -26.23% | Maintains | a month ago |
Opus Genetics IncIRD | 1 | Buy | $8.00 | +227.87% | Initiates Coverage On | a month ago |
Protagonist Therapeutics IncPTGX | 3 | Buy | $86.00 | -6.78% | Maintains | a month ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Buy | $18.00 | +27.93% | Maintains | 2 months ago |
Passage Bio IncPASG | 3 | Buy | $40.00 | +274.53% | Maintains | 4 months ago |
Sagimet Biosciences IncSGMT | 1 | Buy | $28.00 | +342.34% | Initiates Coverage On | 4 months ago |
Voyager Therapeutics IncVYGR | 1 | Buy | $8.00 | +81.41% | Maintains | 4 months ago |
Camp4 Therapeutics CorpCAMP | 1 | Buy | $8.00 | +33.11% | Initiates Coverage On | 7 months ago |
Rocket Pharmaceuticals IncRCKT | 2 | Buy | $32.00 | +827.54% | Reiterates | 7 months ago |
Rezolute IncRZLT | 1 | Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Anavex Life Sciences CorpAVXL | 2 | Strong Buy | $28.00 | N/A | Maintains | 3 years ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $3.00 | N/A | Maintains | 3 years ago |
Tectonic Therapeutic IncTECX | 2 | Strong Buy | $48.00 | N/A | Upgrades | 3 years ago |
Applied Genetic Technologies CorpAGTC | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Renovacor IncRCOR | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Strong Buy | $75.00 | N/A | Maintains | 3 years ago |
Lenz Therapeutics IncLENZ | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 4 years ago |
Bluebird Bio IncBLUE | 2 | Hold | $700.00 | N/A | Downgrades | 4 years ago |
Uniqure NvQURE | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 4 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 4 years ago |
Sio Gene Therapies IncSIOX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 4 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $44.00 | N/A | Initiates Coverage On | 4 years ago |
Mereo Biopharma Group PLCMREO | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Nightstar Therapeutics PLCNITE1 | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.